Hydroquinone: Difference between revisions
m s/:/./ |
m →Skin depigmentation: Typo fixing, replaced: -blity → -bility |
||
(28 intermediate revisions by 21 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
{{Short description|Chemical compound}} |
||
{{Use dmy dates|date=January 2024}} |
|||
{{chembox |
{{chembox |
||
| Watchedfields = changed |
| Watchedfields = changed |
||
Line 12: | Line 13: | ||
| ImageFile2 = Hydroquinone crystal.jpg |
| ImageFile2 = Hydroquinone crystal.jpg |
||
| PIN = Benzene-1,4-diol<ref name=iupac2013>{{cite book | title = Nomenclature of Organic Chemistry : IUPAC Recommendations and Preferred Names 2013 (Blue Book) | publisher = [[Royal Society of Chemistry|The Royal Society of Chemistry]] | date = 2014 | location = Cambridge | page = 691 | doi = 10.1039/9781849733069-FP001 | isbn = 978-0-85404-182-4| chapter = Front Matter }}</ref> |
| PIN = Benzene-1,4-diol<ref name=iupac2013>{{cite book | title = Nomenclature of Organic Chemistry : IUPAC Recommendations and Preferred Names 2013 (Blue Book) | publisher = [[Royal Society of Chemistry|The Royal Society of Chemistry]] | date = 2014 | location = Cambridge | page = 691 | doi = 10.1039/9781849733069-FP001 | isbn = 978-0-85404-182-4| chapter = Front Matter }}</ref> |
||
| OtherNames = Hydroquinone<ref name=iupac2013 /><br />Idrochinone<br />Quinol<br />1,4-Dihydroxybenzene<br />p- |
| OtherNames = Hydroquinone<ref name=iupac2013 /><br />Idrochinone<br />Quinol<br />4-Hydroxyphenol<br />1,4-Dihydroxybenzene<br />''p''-Dihydroxybenzene<br />''p''-Benzenediol |
||
|Section1={{Chembox Identifiers |
|Section1={{Chembox Identifiers |
||
| ChEBI_Ref = {{ebicite|correct|EBI}} |
| ChEBI_Ref = {{ebicite|correct|EBI}} |
||
Line 48: | Line 49: | ||
| MeltingPtC = 172 |
| MeltingPtC = 172 |
||
| BoilingPtC = 287 |
| BoilingPtC = 287 |
||
| pKa = 9.9<ref>{{cite web |url= http://www.inchem.org/documents/sids/sids/123319.pdf |title= Hydroquinone |publisher= UNEP Publications |work= [[OECD SIDS]] }}</ref> |
| pKa = 9.9<ref>{{cite web |url= http://www.inchem.org/documents/sids/sids/123319.pdf |title= Hydroquinone |publisher= UNEP Publications |work= [[OECD SIDS]] |access-date= 17 September 2018 |archive-date= 20 October 2016 |archive-url= https://web.archive.org/web/20161020081945/http://www.inchem.org/documents/sids/sids/123319.pdf |url-status= dead }}</ref> |
||
| VaporPressure = {{val|e=-5|u=mmHg}} (20 °C)<ref name=PGCH/> |
| VaporPressure = {{val|e=-5|u=mmHg}} (20 °C)<ref name=PGCH/> |
||
| MagSus = {{val|-64.63e-6|u=cm<sup>3</sup>/mol}} |
| MagSus = {{val|-64.63e-6|u=cm<sup>3</sup>/mol}} |
||
Line 55: | Line 56: | ||
| Dipole = {{val|1.4|0.1|u=[[Debye|D]]}}<ref>{{cite journal|doi=10.1021/ja01218a051|title=The Dipole Moments of Catechol, Resorcinol and Hydroquinone|year=1945|last1=Lander|first1=John J.|last2=Svirbely|first2=John J. Lander, W. J.|journal=Journal of the American Chemical Society|volume=67|issue=2|pages=322–324}}</ref> |
| Dipole = {{val|1.4|0.1|u=[[Debye|D]]}}<ref>{{cite journal|doi=10.1021/ja01218a051|title=The Dipole Moments of Catechol, Resorcinol and Hydroquinone|year=1945|last1=Lander|first1=John J.|last2=Svirbely|first2=John J. Lander, W. J.|journal=Journal of the American Chemical Society|volume=67|issue=2|pages=322–324}}</ref> |
||
}} |
}} |
||
|Section6={{Chembox Pharmacology |
| Section6 = {{Chembox Pharmacology |
||
| Pharmacology_ref = |
|||
| ATCCode_prefix = D11 |
| ATCCode_prefix = D11 |
||
| ATCCode_suffix = AX11 |
| ATCCode_suffix = AX11 |
||
| ATC_Supplemental = |
|||
⚫ | |||
| ATCvet = |
|||
| Licence_EU = |
|||
| INN = |
|||
| INN_EMA = |
|||
| Licence_US = |
|||
| Legal_status = |
|||
| Legal_AU = |
|||
| Legal_AU_comment = |
|||
| Legal_CA = |
|||
| Legal_CA_comment = |
|||
| Legal_NZ = |
|||
| Legal_NZ_comment = |
|||
| Legal_UK = |
|||
| Legal_UK_comment = |
|||
| Legal_US = |
|||
| Legal_US_comment = |
|||
| Legal_EU = |
|||
| Legal_EU_comment = |
|||
| Legal_UN = |
|||
| Legal_UN_comment = |
|||
| Pregnancy_category = |
|||
| Pregnancy_AU = |
|||
| Pregnancy_AU_comment = |
|||
| Dependence_liability = |
|||
| AdminRoutes = |
|||
| Bioavail = |
|||
| ProteinBound = |
|||
| Metabolism = |
|||
| Metabolites = |
|||
| OnsetOfAction = |
|||
| HalfLife = |
|||
| DurationOfAction = |
|||
| Excretion = |
|||
⚫ | |||
|Section7={{Chembox Hazards |
|Section7={{Chembox Hazards |
||
| ExternalSDS = |
| ExternalSDS = |
||
Line 64: | Line 100: | ||
| NFPA-F = 1 |
| NFPA-F = 1 |
||
| NFPA-R = |
| NFPA-R = |
||
| NFPA_ref =<ref>{{cite web |url=http://assets.openstudy.com/updates/attachments/4f0d5cb6e4b084a815fccd72-chmvijay-1326448458607-dipolemoment.pdf |title=Archived copy |access-date= |
| NFPA_ref =<ref>{{cite web |url=http://assets.openstudy.com/updates/attachments/4f0d5cb6e4b084a815fccd72-chmvijay-1326448458607-dipolemoment.pdf |title=Archived copy |access-date=25 January 2014 |url-status=live |archive-url=https://web.archive.org/web/20140202184040/http://assets.openstudy.com/updates/attachments/4f0d5cb6e4b084a815fccd72-chmvijay-1326448458607-dipolemoment.pdf |archive-date=2 February 2014 }}</ref> |
||
| GHSPictograms = {{GHS05}}{{GHS07}}{{GHS08}}{{GHS09}} |
| GHSPictograms = {{GHS05}}{{GHS07}}{{GHS08}}{{GHS09}} |
||
| GHSSignalWord = Danger |
| GHSSignalWord = Danger |
||
Line 83: | Line 119: | ||
'''Hydroquinone''', also known as '''benzene-1,4-diol''' or '''quinol''', is an [[aromatic]] [[organic compound]] that is a type of [[Phenols|phenol]], a derivative of [[benzene]], having the [[chemical formula]] C<sub>6</sub>H<sub>4</sub>(OH)<sub>2</sub>. It has two [[hydroxyl group]]s [[covalent bond|bonded]] to a [[benzene ring]] in a [[Arene substitution patterns#Ortho, meta, and para substitution|''para'']] position. It is a white granular [[solid]]. Substituted derivatives of this parent compound are also referred to as hydroquinones. The name "hydroquinone" was coined by [[Friedrich Wöhler]] in 1843.<ref>F. Wöhler (1844) "Untersuchungen über das Chinon" (Investigations of quinone), ''Annalen der Chemie und Pharmacie'', '''51''' : 145-163. [http://babel.hathitrust.org/cgi/pt?id=uva.x002457921;view=1up;seq=158 From page 146:] ''"Das so erhaltene Destillat … enthält … einen neuen, krystallisierenden Körper, den ich unter dem Namen ''farbloses Hydrochinon'' weiter unten näher beschreiben werde."'' (The distillate so obtained … contains … a new, crystallizable substance, that I will describe, under the name of ''colorless hydroquinone'', further below in more detail.) [Note: Wöhler's empirical formula for hydroquinone (p. 152) is incorrect because (1) he attributed 25 (instead of 24) carbon atoms to the molecule, and (2) as many chemists at the time did, he used the wrong atomic masses for carbon (6 instead of 12) and oxygen (8 instead of 16). With these corrections, his empirical formula becomes: C<sub>12</sub>H<sub>12</sub>O<sub>4</sub>. Dividing the subscripts by 2, the result is: C<sub>6</sub>H<sub>6</sub>O<sub>2</sub>, which is correct.]</ref> |
'''Hydroquinone''', also known as '''benzene-1,4-diol''' or '''quinol''', is an [[aromatic]] [[organic compound]] that is a type of [[Phenols|phenol]], a derivative of [[benzene]], having the [[chemical formula]] C<sub>6</sub>H<sub>4</sub>(OH)<sub>2</sub>. It has two [[hydroxyl group]]s [[covalent bond|bonded]] to a [[benzene ring]] in a [[Arene substitution patterns#Ortho, meta, and para substitution|''para'']] position. It is a white granular [[solid]]. Substituted derivatives of this parent compound are also referred to as hydroquinones. The name "hydroquinone" was coined by [[Friedrich Wöhler]] in 1843.<ref>F. Wöhler (1844) "Untersuchungen über das Chinon" (Investigations of quinone), ''Annalen der Chemie und Pharmacie'', '''51''' : 145-163. [http://babel.hathitrust.org/cgi/pt?id=uva.x002457921;view=1up;seq=158 From page 146:] ''"Das so erhaltene Destillat … enthält … einen neuen, krystallisierenden Körper, den ich unter dem Namen ''farbloses Hydrochinon'' weiter unten näher beschreiben werde."'' (The distillate so obtained … contains … a new, crystallizable substance, that I will describe, under the name of ''colorless hydroquinone'', further below in more detail.) [Note: Wöhler's empirical formula for hydroquinone (p. 152) is incorrect because (1) he attributed 25 (instead of 24) carbon atoms to the molecule, and (2) as many chemists at the time did, he used the wrong atomic masses for carbon (6 instead of 12) and oxygen (8 instead of 16). With these corrections, his empirical formula becomes: C<sub>12</sub>H<sub>12</sub>O<sub>4</sub>. Dividing the subscripts by 2, the result is: C<sub>6</sub>H<sub>6</sub>O<sub>2</sub>, which is correct.]</ref> |
||
In 2021, it was the 282nd most commonly prescribed medication in the United States, with more than 800,000 prescriptions.<ref>{{cite web | title=The Top 300 of 2021 | url=https://clincalc.com/DrugStats/Top300Drugs.aspx | website=ClinCalc | access-date=14 January 2024 | archive-date=15 January 2024 | archive-url=https://web.archive.org/web/20240115223848/https://clincalc.com/DrugStats/Top300Drugs.aspx | url-status=live }}</ref><ref>{{cite web | title = Hydroquinone - Drug Usage Statistics | website = ClinCalc | url = https://clincalc.com/DrugStats/Drugs/Hydroquinone | access-date = 14 January 2024}}</ref> |
|||
==Production== |
==Production== |
||
Hydroquinone is produced industrially |
Hydroquinone is produced industrially in two main ways.<ref name=Ullmann>Phillip M. Hudnall "Hydroquinone" in Ullmann's Encyclopedia of Industrial Chemistry 2002, Wiley-VCH, Weinheim. 2005 Wiley-VCH, Weinheim. {{doi|10.1002/14356007.a13_499}}.</ref> |
||
* The most widely used route is similar to the [[cumene process]] in reaction mechanism and involves the dialkylation of [[benzene]] with [[propene]] to give 1,4-diisopropylbenzene. This compound reacts with air to afford the bis(hydroperoxide), which is structurally similar to [[cumene hydroperoxide]] and rearranges in acid to give [[acetone]] and hydroquinone.<ref>Gerhard Franz, Roger A. Sheldon "Oxidation" in ''Ullmann's Encyclopedia of Industrial Chemistry'', Wiley-VCH, Weinheim, 2000 {{ |
* The most widely used route is similar to the [[cumene process]] in reaction mechanism and involves the dialkylation of [[benzene]] with [[propene]] to give 1,4-diisopropylbenzene. This compound reacts with air to afford the bis(hydroperoxide), which is structurally similar to [[cumene hydroperoxide]] and rearranges in acid to give [[acetone]] and hydroquinone.<ref>Gerhard Franz, Roger A. Sheldon "Oxidation" in ''Ullmann's Encyclopedia of Industrial Chemistry'', Wiley-VCH, Weinheim, 2000 {{doi|10.1002/14356007.a18_261}}</ref> |
||
* A second route involves [[hydroxylation]] of [[phenol]] over a catalyst. The conversion uses [[hydrogen peroxide]] and affords a mixture of hydroquinone and its ortho isomer [[catechol]] (benzene-1,2-diol): |
* A second route involves [[hydroxylation]] of [[phenol]] over a catalyst. The conversion uses [[hydrogen peroxide]] and affords a mixture of hydroquinone and its ortho isomer [[catechol]] (benzene-1,2-diol): |
||
*:<chem>C6H5OH + H2O2 -> C6H4(OH)2 + H2O</chem> |
|||
::C<sub>6</sub>H<sub>5</sub>OH + H<sub>2</sub>O<sub>2</sub> → C<sub>6</sub>H<sub>4</sub>(OH)<sub>2</sub> + H<sub>2</sub>O |
|||
Other, less common methods include: |
Other, less common methods include: |
||
* A potentially significant synthesis of hydroquinone from [[acetylene]] and [[iron pentacarbonyl]] has been proposed<ref name=Cyclization>{{cite journal|author1=Reppe, Walter |author2=Kutepow, N |author3=Magin, A |title=Cyclization of Acetylenic Compounds|journal=Angewandte Chemie International Edition in English|year=1969|volume=8|issue=10|pages=727–733|doi=10.1002/anie.196907271}}</ref><ref>{{cite book|author1=Hubel, Karl |author2=Braye, Henri|title=Process for the preparation of substituted cyclic compounds and products resulting therefrom US3149138 A|year=1960|publisher=Union Carbide Corp.|url=https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3149138.pdf}}</ref><ref>{{cite book|author1=Pino, Piero |author2=Braca, Giuseppe |author3=Sbrana, Glauco |title=Preparation of hydroquinone US3355503 A|year=1964|publisher=Lonza Ag|url=https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3355503.pdf}}</ref><ref>{{cite book|author1=Walter, Reppe |author2=Magin, August|title=Production of hydroquinones US3394193 A|year=1966|publisher=Basf Ag|url=https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3394193.pdf}}</ref><ref>{{cite book|author1=Piero, Pino |author2=Giuseppe, Braca |author3=Frediano, Settimo |author4=Glauco, Sbrana |title=Preparation of hydroquinone US3459812 A|year=1967|publisher=Lonza Ag|url=https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3459812.pdf}}</ref><ref>{{cite book|author1=Holmes, J. |author2=Hagemeyer, H.|title=Process for the production of hydroquinone US 3742071 A|year=1971|publisher=Eastman Kodak Co.|url=https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3742071.pdf}}</ref> Iron pentacarbonyl serves as a [[catalyst]], rather than as a [[reagent]], in the presence of free [[carbon monoxide]] gas. [[Rhodium]] or [[ruthenium]] can substitute for iron as the catalyst with favorable chemical yields but are not typically used due to their cost of recovery from the reaction mixture.<ref name=Cyclization /> |
* A potentially significant synthesis of hydroquinone from [[acetylene]] and [[iron pentacarbonyl]] has been proposed<ref name=Cyclization>{{cite journal|author1=Reppe, Walter |author2=Kutepow, N |author3=Magin, A |title=Cyclization of Acetylenic Compounds|journal=Angewandte Chemie International Edition in English|year=1969|volume=8|issue=10|pages=727–733|doi=10.1002/anie.196907271}}</ref><ref>{{cite book|author1=Hubel, Karl |author2=Braye, Henri|title=Process for the preparation of substituted cyclic compounds and products resulting therefrom US3149138 A|year=1960|publisher=Union Carbide Corp.|url=https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3149138.pdf}}</ref><ref>{{cite book|author1=Pino, Piero |author2=Braca, Giuseppe |author3=Sbrana, Glauco |title=Preparation of hydroquinone US3355503 A|year=1964|publisher=Lonza Ag|url=https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3355503.pdf}}</ref><ref>{{cite book|author1=Walter, Reppe |author2=Magin, August|title=Production of hydroquinones US3394193 A|year=1966|publisher=Basf Ag|url=https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3394193.pdf}}</ref><ref>{{cite book|author1=Piero, Pino |author2=Giuseppe, Braca |author3=Frediano, Settimo |author4=Glauco, Sbrana |title=Preparation of hydroquinone US3459812 A|year=1967|publisher=Lonza Ag|url=https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3459812.pdf}}</ref><ref>{{cite book|author1=Holmes, J. |author2=Hagemeyer, H.|title=Process for the production of hydroquinone US 3742071 A|year=1971|publisher=Eastman Kodak Co.|url=https://docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US3742071.pdf}}</ref> Iron pentacarbonyl serves as a [[catalyst]], rather than as a [[reagent]], in the presence of free [[carbon monoxide]] gas. [[Rhodium]] or [[ruthenium]] can substitute for iron as the catalyst with favorable chemical yields but are not typically used due to their cost of recovery from the reaction mixture.<ref name=Cyclization /> |
||
* Hydroquinone and its [[Derivative (chemistry)|derivatives]] can also be prepared by oxidation of various phenols. Examples include [[Elbs persulfate oxidation]] and [[Dakin oxidation]]. |
* Hydroquinone and its [[Derivative (chemistry)|derivatives]] can also be prepared by oxidation of various phenols, such as [[aniline]] and [[Diisopropylbenzene|DIPB]].<ref name=":1">{{Cite journal |vauthors=Shi Y, Xia Y, Xu G, Wen L, Gao G, Zong B |date=28 October 2021 |title=Hydrogen peroxide and applications in green hydrocarbon nitridation and oxidation |doi=10.1016/j.cjche.2021.09.030 |journal=Chinese Journal of Chemical Engineering |type=Review article |volume=41 |pages=145–161|s2cid=240248911 }}</ref> Examples include [[Elbs persulfate oxidation]] and [[Dakin oxidation]]. |
||
* Hydroquinone was first obtained in 1820 by the French chemists [[Pierre Joseph Pelletier|Pelletier]] and [[Joseph Bienaimé Caventou|Caventou]] via the [[dry distillation]] of [[quinic acid]].<ref>See: |
* Hydroquinone was first obtained in 1820 by the French chemists [[Pierre Joseph Pelletier|Pelletier]] and [[Joseph Bienaimé Caventou|Caventou]] via the [[dry distillation]] of [[quinic acid]].<ref>See: |
||
* Pelletier and Caventou (1820) "Recherches chimiques sur les quinquinas" (Chemical investigations of quinquinas [i.e., the bark of various [[Cinchona]] trees]), ''Annales de Chimie et de Physique'', 2nd series, '''15''' : |
* Pelletier and Caventou (1820) "Recherches chimiques sur les quinquinas" (Chemical investigations of quinquinas [i.e., the bark of various [[Cinchona]] trees]), ''Annales de Chimie et de Physique'', 2nd series, '''15''' : 289–318, 337-364. [http://babel.hathitrust.org/cgi/pt?id=hvd.hx3dvm;view=1up;seq=347 On pages 341-342], the preparation and properties of ''l'acide pyro-kinique'' (pyroquinic acid or hydroquinone) are discussed. |
||
* {{cite book|last=Roscoe|first=Henry|title=A Treatise on Chemistry, Volume 3, Part 3|year=1891|publisher=Macmillan & Co.|location=London|pages=165|url=https://books.google.com/books?id=HEY9AAAAYAAJ&pg=PA165}}</ref> |
* {{cite book|last=Roscoe|first=Henry|title=A Treatise on Chemistry, Volume 3, Part 3|year=1891|publisher=Macmillan & Co.|location=London|pages=165|url=https://books.google.com/books?id=HEY9AAAAYAAJ&pg=PA165}}</ref> |
||
* [[Hydrolysis]] of chlorinated [[phenol]], described as being used in China.<ref name=":1" /> |
|||
Note that methods such as hydrolysis of chlorinated phenol and oxidation of phenols are much more polluting methods than some others.<ref name=":1" /> |
|||
==Reactions== |
==Reactions== |
||
Line 102: | Line 142: | ||
Hydroquinone undergoes [[oxidation]] under mild conditions to give [[1,4-Benzoquinone|benzoquinone]]. This process can be reversed. Some naturally occurring hydroquinone derivatives exhibit this sort of reactivity, one example being [[coenzyme Q]]. Industrially this reaction is exploited both with hydroquinone itself but more often with its derivatives where one OH has been replaced by an amine. |
Hydroquinone undergoes [[oxidation]] under mild conditions to give [[1,4-Benzoquinone|benzoquinone]]. This process can be reversed. Some naturally occurring hydroquinone derivatives exhibit this sort of reactivity, one example being [[coenzyme Q]]. Industrially this reaction is exploited both with hydroquinone itself but more often with its derivatives where one OH has been replaced by an amine. |
||
When colorless hydroquinone and benzoquinone, a bright yellow solid, are [[cocrystal]]lized in a 1:1 ratio, a dark-green crystalline [[charge-transfer complex]] ([[melting point]] 171 °C) called [[quinhydrone]] ( |
When colorless hydroquinone and benzoquinone, a bright yellow solid, are [[cocrystal]]lized in a 1:1 ratio, a dark-green crystalline [[charge-transfer complex]] ([[melting point]] 171 °C) called [[quinhydrone]] ({{chem2|C6H6O2*C6H4O2}}) is formed. This complex dissolves in hot water, where the two molecules dissociate in solution.<ref>{{Cite book|title=Introduction to organic chemistry|author=Streitwieser, Andrew|date=1992|publisher=Prentice Hall|others=Heathcock, Clayton H., 1936-, Kosower, Edward M.|isbn=978-0139738500|edition= 4th|location=Upper Saddle River, N.J.|oclc=52836313}}</ref> |
||
===Amination=== |
===Amination=== |
||
An important reaction is the conversion of hydroquinone to the mono- and diamine derivatives. [[Methylaminophenol]], used in photography, is produced in this way:<ref name=Ullmann/> |
An important reaction is the conversion of hydroquinone to the mono- and diamine derivatives. [[Methylaminophenol]], used in photography, is produced in this way:<ref name=Ullmann/> |
||
:<chem>C6H4(OH)2 + \overset{methylamine}{CH3NH2} -> HOC6H4NHCH3 + H2O</chem> |
|||
:C<sub>6</sub>H<sub>4</sub>(OH)<sub>2</sub> + [[Methylamine|CH<sub>3</sub>NH<sub>2</sub>]] → HOC<sub>6</sub>H<sub>4</sub>NHCH<sub>3</sub> + H<sub>2</sub>O |
|||
Diamines, useful in the rubber industry as antiozone agents, are similarly produced from [[aniline]]: |
|||
:<chem>C6H4(OH)2 + \overset{aniline}{2 C6H5NH2} -> C6H4(N(H)C6H5)2 + 2 H2O</chem> |
|||
:C<sub>6</sub>H<sub>4</sub>(OH)<sub>2</sub> + 2 C<sub>6</sub>H<sub>5</sub>NH<sub>2</sub> → C<sub>6</sub>H<sub>4</sub>(N(H)C<sub>6</sub>H<sub>5</sub>)<sub>2</sub> + 2 H<sub>2</sub>O |
|||
==Uses== |
==Uses== |
||
Line 118: | Line 158: | ||
=== Skin depigmentation === |
=== Skin depigmentation === |
||
Hydroquinone is used as a topical application in [[skin whitening]] to reduce the [[color]] of skin. It does not have the same predisposition to cause [[dermatitis]] as [[metol]] does. This is a prescription-only ingredient in some countries, including the member states of the European Union under [[Directive (European Union)|Directives]] 76/768/EEC:1976.<ref> |
Hydroquinone is used as a topical application in [[skin whitening]] to reduce the [[color]] of skin. It does not have the same predisposition to cause [[dermatitis]] as [[metol]] does. This is a prescription-only ingredient in some countries, including the member states of the European Union under [[Directive (European Union)|Directives]] 76/768/EEC:1976.<ref>{{CELEX|31976L0768|text=Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products}}</ref><ref>{{cite web|url=https://www.beskinformed.com/hydroquinone/clear-n-smooth-skin-toning-cream-recalled/|title=Clear N Smooth Skin Toning Cream recalled|date=4 October 2011|access-date=4 April 2018}}</ref> |
||
In 2006, the United States [[Food and Drug Administration]] revoked its previous approval of hydroquinone and proposed a ban on all [[over-the-counter]] preparations.<ref name="FDA 2006">{{cite report | author = United States Food and Drug Administration | year = 2006 | title = Skin Bleaching Drug Products for Over-the-Counter Product Use; Proposed Rule | url = https://www.fda.gov/OHRMS/DOCKETS/98fr/78n-0065-npr0003.pdf | docket = 1978N-0065 | url-status = live | archive-url = https://web.archive.org/web/20110516100158/https://www.fda.gov/OHRMS/DOCKETS/98fr/78n-0065-npr0003.pdf | archive-date = |
In 2006, the United States [[Food and Drug Administration]] revoked its previous approval of hydroquinone and proposed a ban on all [[over-the-counter]] preparations.<ref name="FDA 2006">{{cite report | author = United States Food and Drug Administration | year = 2006 | title = Skin Bleaching Drug Products for Over-the-Counter Product Use; Proposed Rule | url = https://www.fda.gov/OHRMS/DOCKETS/98fr/78n-0065-npr0003.pdf | docket = 1978N-0065 | url-status = live | archive-url = https://web.archive.org/web/20110516100158/https://www.fda.gov/OHRMS/DOCKETS/98fr/78n-0065-npr0003.pdf | archive-date = 16 May 2011 }}</ref> The FDA officially banned hydroquinone in 2020 as part of a larger reform of the over-the-counter drug review process.<ref>{{Cite web|title=Congress Enacts OTC Monograph Reform|url=https://www.jdsupra.com/legalnews/congress-enacts-otc-monograph-reform-96907/|access-date=19 December 2021|website=JD Supra|language=en}}</ref> The FDA stated that hydroquinone cannot be ruled out as a potential [[carcinogen]].<ref name=":0">{{Cite web|url=https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm203112.htm|title=About the Center for Drug Evaluation and Research - Hydroquinone Studies Under The National Toxicology Program (NTP)|last=Research|first=Center for Drug Evaluation and|website=www.fda.gov|language=en|access-date=12 February 2017|url-status=live|archive-url=https://web.archive.org/web/20170122222134/https://www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm203112.htm|archive-date=22 January 2017}}</ref> This conclusion was reached based on the extent of [[absorption (pharmacokinetics)|absorption]] in humans and the incidence of [[neoplasm]]s in rats in several studies where adult rats were found to have increased rates of tumours, including [[thyroid follicular cell hyperplasia]]s, anisokaryosis (variation in nuclei sizes), mononuclear cell leukemia, [[hepatocellular adenoma]]s and [[kidney cancer|renal tubule cell adenoma]]s. The Campaign for Safe Cosmetics has also highlighted concerns.<ref>[http://www.safecosmetics.org/article.php?id=289 Campaign For Safe Cosmetics - Hydroquinone] {{webarchive|url=https://web.archive.org/web/20101127071016/http://safecosmetics.org/article.php?id=289 |date=27 November 2010 }}</ref> |
||
Numerous studies have revealed that hydroquinone, if taken orally, can cause exogenous [[ochronosis]], a disfiguring disease in which blue-black pigments are deposited onto the skin; however, skin preparations containing the ingredient are administered topically. The FDA had classified hydroquinone in 1982 as a safe product - generally recognized as safe and effective (GRASE), however additional studies under the National Toxicology Program (NTP) were suggested in order to determine whether there is a risk to humans from the use of hydroquinone.<ref name="FDA 2006"/><ref>{{cite journal |author1=Olumide, YM |author2=Akinkugbe, AO |author3=Altraide, D |author4=Mohammed, T |author5=Ahamefule, N |author6=Ayanlowo, S |author7=Onyekonwu, C |author8=Essen, N | title=Complications of chronic use of skin lightening cosmetics| date= April 2008 | volume = 47 | issue = 4 | pmid=18377596 |pages = 344–53 | journal = International Journal of Dermatology | doi=10.1111/j.1365-4632.2008.02719.x|s2cid=8159382 }}</ref><ref name=":0" /> NTP evaluation showed some evidence of long-term carcinogenic and genotoxic effects<ref>{{Cite web|url=https://ntp.niehs.nih.gov/ |
Numerous studies have revealed that hydroquinone, if taken orally, can cause exogenous [[ochronosis]], a disfiguring disease in which blue-black pigments are deposited onto the skin; however, skin preparations containing the ingredient are administered topically. The FDA had classified hydroquinone in 1982 as a safe product - generally recognized as safe and effective (GRASE), however additional studies under the National Toxicology Program (NTP) were suggested in order to determine whether there is a risk to humans from the use of hydroquinone.<ref name="FDA 2006"/><ref>{{cite journal |author1=Olumide, YM |author2=Akinkugbe, AO |author3=Altraide, D |author4=Mohammed, T |author5=Ahamefule, N |author6=Ayanlowo, S |author7=Onyekonwu, C |author8=Essen, N | title=Complications of chronic use of skin lightening cosmetics| date= April 2008 | volume = 47 | issue = 4 | pmid=18377596 |pages = 344–53 | journal = International Journal of Dermatology | doi=10.1111/j.1365-4632.2008.02719.x|s2cid=8159382 }}</ref><ref name=":0" /> NTP evaluation showed some evidence of long-term carcinogenic and genotoxic effects<ref>{{Cite web |title=Hydroquinone 10022-H |url=https://ntp.niehs.nih.gov/static/whatwestudy/testpgm/status/ts-10022-h.html |url-status=live |archive-url=https://web.archive.org/web/20171001031226/https://ntp.niehs.nih.gov/testing/status/agents/ts-10022-h.html |archive-date=1 October 2017 |access-date=18 August 2023 |website=ntp.niehs.nih.gov |language=en-US}}</ref> |
||
⚫ | While hydroquinone remains widely prescribed for treatment of [[hyperpigmentation]], questions raised about its safety profile by regulatory agencies in the EU, Japan, and USA encourage the search for other agents with comparable efficacy.<ref>{{Cite journal|last=Draelos|first=Zoe Diana|date=1 September 2007|title=Skin lightening preparations and the hydroquinone controversy|journal=Dermatologic Therapy|volume=20|issue=5|pages=308–313|doi=10.1111/j.1529-8019.2007.00144.x|issn=1529-8019|pmid=18045355|s2cid=24913995|doi-access=free}}</ref> Several such agents are already available or under research,<ref>{{Cite journal|last=Bandyopadhyay|first=Debabrata|date=1 January 2009|journal=Indian Journal of Dermatology|volume=54|issue=4|pages=303–309|doi=10.4103/0019-5154.57602|issn=0019-5154|pmc=2807702|pmid=20101327|title=Topical treatment of melasma |doi-access=free }}</ref> including [[azelaic acid]],<ref>{{Cite journal|last1=Mazurek|first1=Klaudia|last2=Pierzchała|first2=Ewa|date=1 September 2016|title=Comparison of efficacy of products containing azelaic acid in melasma treatment|journal=Journal of Cosmetic Dermatology|volume=15|issue=3|pages=269–282|doi=10.1111/jocd.12217|issn=1473-2165|pmid=27028014|s2cid=25303091}}</ref> [[kojic acid]], retinoids, cysteamine,<ref>{{Cite journal|last1=Mansouri|first1=P.|last2=Farshi|first2=S.|last3=Hashemi|first3=Z.|last4=Kasraee|first4=B.|date=1 July 2015|title=Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial|journal=The British Journal of Dermatology|volume=173|issue=1|pages=209–217|doi=10.1111/bjd.13424|issn=1365-2133|pmid=25251767|s2cid=21618233}}</ref> topical steroids, [[glycolic acid]], and other substances. One of these, [[4-butylresorcinol]], has been proved to be more effective at treating melanin-related skin disorders by a wide margin, as well as safe enough to be made available over the counter.<ref>{{cite book|title=Phenols—Advances in Research and Application: 2013 Edition|date=2013|page=76|chapter=Hydroquinones|publisher=Scholastic}}</ref> |
||
While using hydroquinone as a lightening agent can be effective with proper use, it can also cause skin sensitivity. Using a daily sunscreen with a high [[Sunscreen#Persistent pigment darkening|PPD (persistent pigment darkening)]] rating reduces the risk of further damage. Hydroquinone is sometimes combined with [[alpha-hydroxy acids]] that exfoliate the skin to quicken the lightening process. In the United States, topical treatments usually contain up to 2% in hydroquinone. Otherwise, higher concentrations (up to 4%) should be prescribed and used with caution. |
|||
In the [[anthraquinone process]] substituted hydroquinones, typically anthrahydroquinone are used to produce [[hydrogen peroxide]] which forms spontaneously on reaction with oxygen. The type of substituted hydroquinone is selected depending on reactivity and recyclability. |
|||
⚫ | While hydroquinone remains widely prescribed for treatment of [[hyperpigmentation]], questions raised about its safety profile by regulatory agencies in the EU, Japan, and USA encourage the search for other agents with comparable efficacy.<ref>{{Cite journal|last=Draelos|first=Zoe Diana|date=2007 |
||
==Natural occurrences== |
==Natural occurrences== |
||
Hydroquinones are one of the two primary reagents in the defensive glands of [[bombardier beetle]]s, along with [[hydrogen peroxide]] (and perhaps other compounds, depending on the species), which collect in a reservoir. The reservoir opens through a muscle-controlled valve onto a thick-walled reaction chamber. This chamber is lined with cells that secrete [[catalase]]s and [[peroxidase]]s. When the contents of the reservoir are forced into the reaction chamber, the catalases and peroxidases rapidly break down the hydrogen peroxide and [[catalysis|catalyze]] the [[oxidation]] of the hydroquinones into [[quinone|''p''-quinones]]. These reactions release free oxygen and generate enough heat to bring the mixture to the boiling point and vaporize about a fifth of it, producing a hot spray from the beetle's [[abdomen]].<ref name="Solomons">Organic Chemistry, Solomon and Fryhle, 10th edition, Wiley Publishing, 2010.{{page needed|date=October 2016}}</ref> |
Hydroquinones are one of the two primary reagents in the defensive glands of [[bombardier beetle]]s, along with [[hydrogen peroxide]] (and perhaps other compounds, depending on the species), which collect in a reservoir. The reservoir opens through a muscle-controlled valve onto a thick-walled reaction chamber. This chamber is lined with cells that secrete [[catalase]]s and [[peroxidase]]s. When the contents of the reservoir are forced into the reaction chamber, the catalases and peroxidases rapidly break down the hydrogen peroxide and [[catalysis|catalyze]] the [[oxidation]] of the hydroquinones into [[quinone|''p''-quinones]]. These reactions release free oxygen and generate enough heat to bring the mixture to the boiling point and vaporize about a fifth of it, producing a hot spray from the beetle's [[abdomen]].<ref name="Solomons">Organic Chemistry, Solomon and Fryhle, 10th edition, Wiley Publishing, 2010.{{page needed|date=October 2016}}</ref> |
||
⚫ | Hydroquinone is thought to be the active toxin in ''[[Agaricus hondensis]]'' mushrooms.<ref>{{cite journal | doi=10.1055/s-2006-957852 |author1=Joval, E |author2=Kroeger, P |author3=N | title=Hydroquinone: the toxic compound of Agaricus hondensis| date= April 1996 | volume = 62 | issue = 2 |pages = 185 | journal = Planta Medica | pmid=17252436|s2cid=260249338 }}</ref> |
||
[[Farnesol|Farnesyl]] hydroquinone derivatives are the principal irritants exuded by the [[poodle-dog bush]], which can cause severe [[contact dermatitis]] in humans. |
|||
⚫ | Hydroquinone is thought to be the active toxin in ''[[Agaricus hondensis]]'' mushrooms.<ref>{{cite journal | doi=10.1055/s-2006-957852 |author1=Joval, E |author2=Kroeger, P |author3=N | title=Hydroquinone: the toxic compound of Agaricus hondensis| date= April 1996 | volume = 62 | issue = 2 |pages = 185 | journal = Planta Medica | pmid=17252436}}</ref> |
||
Hydroquinone has been shown to be one of the chemical constituents of the natural product [[propolis]].<ref name="Propolis">{{cite journal | last1 = Burdock | first1 = G.A. | year = 1998 | title = Review of the biological properties and toxicity of bee propolis (propolis) | journal = Food and Chemical Toxicology | volume = 36 | issue = 4| pages = 347–363 | doi = 10.1016/S0278-6915(97)00145-2 | pmid = 9651052 }}</ref> |
Hydroquinone has been shown to be one of the chemical constituents of the natural product [[propolis]].<ref name="Propolis">{{cite journal | last1 = Burdock | first1 = G.A. | year = 1998 | title = Review of the biological properties and toxicity of bee propolis (propolis) | journal = Food and Chemical Toxicology | volume = 36 | issue = 4| pages = 347–363 | doi = 10.1016/S0278-6915(97)00145-2 | pmid = 9651052 }}</ref> |
||
It is also one of the chemical compounds found in [[castoreum]]. This compound is gathered from the [[beaver]]'s castor sacs.<ref>The Beaver: Its Life and Impact. Dietland Muller-Schwarze, 2003, page 43 ([https://books.google.com/books?id=HZ5WjXB5Pr8C |
It is also one of the chemical compounds found in [[castoreum]]. This compound is gathered from the [[beaver]]'s castor sacs.<ref>The Beaver: Its Life and Impact. Dietland Muller-Schwarze, 2003, page 43 ([https://books.google.com/books?id=HZ5WjXB5Pr8C&dq=Castoreum+beekeeping&pg=PA43 book at google books])</ref> |
||
In [[bearberry]] (''Arctostaphylos uva-ursi''), [[arbutin]] is converted to hydroquinone. |
|||
==See also== |
|||
* [[Photographic developer]] |
|||
* [[Semiquinone]] |
|||
* [[Bombardier beetle]] |
|||
==References== |
==References== |
||
Line 152: | Line 183: | ||
*[http://www.inchem.org/documents/icsc/icsc/eics0166.htm International Chemical Safety Card 0166] |
*[http://www.inchem.org/documents/icsc/icsc/eics0166.htm International Chemical Safety Card 0166] |
||
*[https://www.cdc.gov/niosh/npg/npgd0338.html NIOSH Pocket Guide to Chemical Hazards] |
*[https://www.cdc.gov/niosh/npg/npgd0338.html NIOSH Pocket Guide to Chemical Hazards] |
||
*[https://web.archive.org/web/20051012221212/http://www-cie.iarc.fr/htdocs/monographs/vol71/024-hydroquinone.html IARC Monograph: "Hydroquinone"] |
|||
{{Other dermatological preparations}} |
{{Other dermatological preparations}} |
Latest revision as of 13:46, 7 September 2024
Names | |
---|---|
Preferred IUPAC name
Benzene-1,4-diol[1] | |
Other names | |
Identifiers | |
3D model (JSmol)
|
|
605970 | |
ChEBI | |
ChEMBL | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.004.199 |
EC Number |
|
2742 | |
KEGG | |
PubChem CID
|
|
RTECS number |
|
UNII | |
UN number | 3077, 2662 |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C6H6O2 | |
Molar mass | 110.112 g·mol−1 |
Appearance | White solid |
Density | 1.3 g cm−3, solid |
Melting point | 172 °C (342 °F; 445 K) |
Boiling point | 287 °C (549 °F; 560 K) |
5.9 g/100 mL (15 °C) | |
Vapor pressure | 10−5 mmHg (20 °C)[2] |
Acidity (pKa) | 9.9[3] |
−64.63×10−6 cm3/mol | |
Structure | |
1.4±0.1 D[4] | |
Pharmacology | |
D11AX11 (WHO) | |
Hazards | |
GHS labelling: | |
Danger | |
H302, H317, H318, H341, H351, H400 | |
P201, P202, P261, P264, P270, P272, P273, P280, P281, P301+P312, P302+P352, P305+P351+P338, P308+P313, P310, P321, P330, P333+P313, P363, P391, P405, P501 | |
NFPA 704 (fire diamond) | |
Flash point | 165 °C (329 °F; 438 K) |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
490 mg/kg (mammal, oral) 245 mg/kg (mouse, oral) 200 mg/kg (rabbit, oral) 320 mg/kg (rat, oral) 550 mg/kg (guinea pig, oral) 200 mg/kg (dog, oral) 70 mg/kg (cat, oral)[5] |
NIOSH (US health exposure limits): | |
PEL (Permissible)
|
TWA 2 mg/m3[2] |
REL (Recommended)
|
C 2 mg/m3 [15-minute][2] |
IDLH (Immediate danger)
|
50 mg/m3[2] |
Related compounds | |
Related benzenediols
|
Pyrocatechol Resorcinol |
Related compounds
|
1,4-benzoquinone |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Hydroquinone, also known as benzene-1,4-diol or quinol, is an aromatic organic compound that is a type of phenol, a derivative of benzene, having the chemical formula C6H4(OH)2. It has two hydroxyl groups bonded to a benzene ring in a para position. It is a white granular solid. Substituted derivatives of this parent compound are also referred to as hydroquinones. The name "hydroquinone" was coined by Friedrich Wöhler in 1843.[7]
In 2021, it was the 282nd most commonly prescribed medication in the United States, with more than 800,000 prescriptions.[8][9]
Production
[edit]Hydroquinone is produced industrially in two main ways.[10]
- The most widely used route is similar to the cumene process in reaction mechanism and involves the dialkylation of benzene with propene to give 1,4-diisopropylbenzene. This compound reacts with air to afford the bis(hydroperoxide), which is structurally similar to cumene hydroperoxide and rearranges in acid to give acetone and hydroquinone.[11]
- A second route involves hydroxylation of phenol over a catalyst. The conversion uses hydrogen peroxide and affords a mixture of hydroquinone and its ortho isomer catechol (benzene-1,2-diol):
Other, less common methods include:
- A potentially significant synthesis of hydroquinone from acetylene and iron pentacarbonyl has been proposed[12][13][14][15][16][17] Iron pentacarbonyl serves as a catalyst, rather than as a reagent, in the presence of free carbon monoxide gas. Rhodium or ruthenium can substitute for iron as the catalyst with favorable chemical yields but are not typically used due to their cost of recovery from the reaction mixture.[12]
- Hydroquinone and its derivatives can also be prepared by oxidation of various phenols, such as aniline and DIPB.[18] Examples include Elbs persulfate oxidation and Dakin oxidation.
- Hydroquinone was first obtained in 1820 by the French chemists Pelletier and Caventou via the dry distillation of quinic acid.[19]
- Hydrolysis of chlorinated phenol, described as being used in China.[18]
Note that methods such as hydrolysis of chlorinated phenol and oxidation of phenols are much more polluting methods than some others.[18]
Reactions
[edit]The reactivity of hydroquinone's hydroxyl groups resembles that of other phenols, being weakly acidic. The resulting conjugate base undergoes easy O-alkylation to give mono- and diethers. Similarly, hydroquinone is highly susceptible to ring substitution by Friedel–Crafts reactions such as alkylation. This reaction is exploited en route to popular antioxidants such as 2-tert-butyl-4-methoxyphenol (BHA). The useful dye quinizarin is produced by diacylation of hydroquinone with phthalic anhydride.[10]
Redox
[edit]Hydroquinone undergoes oxidation under mild conditions to give benzoquinone. This process can be reversed. Some naturally occurring hydroquinone derivatives exhibit this sort of reactivity, one example being coenzyme Q. Industrially this reaction is exploited both with hydroquinone itself but more often with its derivatives where one OH has been replaced by an amine.
When colorless hydroquinone and benzoquinone, a bright yellow solid, are cocrystallized in a 1:1 ratio, a dark-green crystalline charge-transfer complex (melting point 171 °C) called quinhydrone (C6H6O2·C6H4O2) is formed. This complex dissolves in hot water, where the two molecules dissociate in solution.[20]
Amination
[edit]An important reaction is the conversion of hydroquinone to the mono- and diamine derivatives. Methylaminophenol, used in photography, is produced in this way:[10]
Diamines, useful in the rubber industry as antiozone agents, are similarly produced from aniline:
Uses
[edit]Hydroquinone has a variety of uses principally associated with its action as a reducing agent that is soluble in water. It is a major component in most black and white photographic developers for film and paper where, with the compound metol, it reduces silver halides to elemental silver.
There are various other uses associated with its reducing power. As a polymerisation inhibitor, exploiting its antioxidant properties, hydroquinone prevents polymerization of acrylic acid, methyl methacrylate, cyanoacrylate, and other monomers that are susceptible to radical-initiated polymerization. By acting as a free radical scavenger, hydroquinone serves to prolong the shelflife of light-sensitive resins such as preceramic polymers.[21]
Hydroquinone can lose a hydrogen cation from both hydroxyl groups to form a diphenolate ion. The disodium diphenolate salt of hydroquinone is used as an alternating comonomer unit in the production of the polymer PEEK.
Skin depigmentation
[edit]Hydroquinone is used as a topical application in skin whitening to reduce the color of skin. It does not have the same predisposition to cause dermatitis as metol does. This is a prescription-only ingredient in some countries, including the member states of the European Union under Directives 76/768/EEC:1976.[22][23]
In 2006, the United States Food and Drug Administration revoked its previous approval of hydroquinone and proposed a ban on all over-the-counter preparations.[24] The FDA officially banned hydroquinone in 2020 as part of a larger reform of the over-the-counter drug review process.[25] The FDA stated that hydroquinone cannot be ruled out as a potential carcinogen.[26] This conclusion was reached based on the extent of absorption in humans and the incidence of neoplasms in rats in several studies where adult rats were found to have increased rates of tumours, including thyroid follicular cell hyperplasias, anisokaryosis (variation in nuclei sizes), mononuclear cell leukemia, hepatocellular adenomas and renal tubule cell adenomas. The Campaign for Safe Cosmetics has also highlighted concerns.[27]
Numerous studies have revealed that hydroquinone, if taken orally, can cause exogenous ochronosis, a disfiguring disease in which blue-black pigments are deposited onto the skin; however, skin preparations containing the ingredient are administered topically. The FDA had classified hydroquinone in 1982 as a safe product - generally recognized as safe and effective (GRASE), however additional studies under the National Toxicology Program (NTP) were suggested in order to determine whether there is a risk to humans from the use of hydroquinone.[24][28][26] NTP evaluation showed some evidence of long-term carcinogenic and genotoxic effects[29]
While hydroquinone remains widely prescribed for treatment of hyperpigmentation, questions raised about its safety profile by regulatory agencies in the EU, Japan, and USA encourage the search for other agents with comparable efficacy.[30] Several such agents are already available or under research,[31] including azelaic acid,[32] kojic acid, retinoids, cysteamine,[33] topical steroids, glycolic acid, and other substances. One of these, 4-butylresorcinol, has been proved to be more effective at treating melanin-related skin disorders by a wide margin, as well as safe enough to be made available over the counter.[34]
In the anthraquinone process substituted hydroquinones, typically anthrahydroquinone are used to produce hydrogen peroxide which forms spontaneously on reaction with oxygen. The type of substituted hydroquinone is selected depending on reactivity and recyclability.
Natural occurrences
[edit]Hydroquinones are one of the two primary reagents in the defensive glands of bombardier beetles, along with hydrogen peroxide (and perhaps other compounds, depending on the species), which collect in a reservoir. The reservoir opens through a muscle-controlled valve onto a thick-walled reaction chamber. This chamber is lined with cells that secrete catalases and peroxidases. When the contents of the reservoir are forced into the reaction chamber, the catalases and peroxidases rapidly break down the hydrogen peroxide and catalyze the oxidation of the hydroquinones into p-quinones. These reactions release free oxygen and generate enough heat to bring the mixture to the boiling point and vaporize about a fifth of it, producing a hot spray from the beetle's abdomen.[35]
Hydroquinone is thought to be the active toxin in Agaricus hondensis mushrooms.[36]
Hydroquinone has been shown to be one of the chemical constituents of the natural product propolis.[37]
It is also one of the chemical compounds found in castoreum. This compound is gathered from the beaver's castor sacs.[38]
References
[edit]- ^ a b "Front Matter". Nomenclature of Organic Chemistry : IUPAC Recommendations and Preferred Names 2013 (Blue Book). Cambridge: The Royal Society of Chemistry. 2014. p. 691. doi:10.1039/9781849733069-FP001. ISBN 978-0-85404-182-4.
- ^ a b c d NIOSH Pocket Guide to Chemical Hazards. "#0338". National Institute for Occupational Safety and Health (NIOSH).
- ^ "Hydroquinone" (PDF). OECD SIDS. UNEP Publications. Archived from the original (PDF) on 20 October 2016. Retrieved 17 September 2018.
- ^ Lander, John J.; Svirbely, John J. Lander, W. J. (1945). "The Dipole Moments of Catechol, Resorcinol and Hydroquinone". Journal of the American Chemical Society. 67 (2): 322–324. doi:10.1021/ja01218a051.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ "Hydroquinone". Immediately Dangerous to Life or Health Concentrations (IDLH). National Institute for Occupational Safety and Health (NIOSH).
- ^ "Archived copy" (PDF). Archived (PDF) from the original on 2 February 2014. Retrieved 25 January 2014.
{{cite web}}
: CS1 maint: archived copy as title (link) - ^ F. Wöhler (1844) "Untersuchungen über das Chinon" (Investigations of quinone), Annalen der Chemie und Pharmacie, 51 : 145-163. From page 146: "Das so erhaltene Destillat … enthält … einen neuen, krystallisierenden Körper, den ich unter dem Namen farbloses Hydrochinon weiter unten näher beschreiben werde." (The distillate so obtained … contains … a new, crystallizable substance, that I will describe, under the name of colorless hydroquinone, further below in more detail.) [Note: Wöhler's empirical formula for hydroquinone (p. 152) is incorrect because (1) he attributed 25 (instead of 24) carbon atoms to the molecule, and (2) as many chemists at the time did, he used the wrong atomic masses for carbon (6 instead of 12) and oxygen (8 instead of 16). With these corrections, his empirical formula becomes: C12H12O4. Dividing the subscripts by 2, the result is: C6H6O2, which is correct.]
- ^ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
- ^ "Hydroquinone - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
- ^ a b c Phillip M. Hudnall "Hydroquinone" in Ullmann's Encyclopedia of Industrial Chemistry 2002, Wiley-VCH, Weinheim. 2005 Wiley-VCH, Weinheim. doi:10.1002/14356007.a13_499.
- ^ Gerhard Franz, Roger A. Sheldon "Oxidation" in Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH, Weinheim, 2000 doi:10.1002/14356007.a18_261
- ^ a b Reppe, Walter; Kutepow, N; Magin, A (1969). "Cyclization of Acetylenic Compounds". Angewandte Chemie International Edition in English. 8 (10): 727–733. doi:10.1002/anie.196907271.
- ^ Hubel, Karl; Braye, Henri (1960). Process for the preparation of substituted cyclic compounds and products resulting therefrom US3149138 A (PDF). Union Carbide Corp.
- ^ Pino, Piero; Braca, Giuseppe; Sbrana, Glauco (1964). Preparation of hydroquinone US3355503 A (PDF). Lonza Ag.
- ^ Walter, Reppe; Magin, August (1966). Production of hydroquinones US3394193 A (PDF). Basf Ag.
- ^ Piero, Pino; Giuseppe, Braca; Frediano, Settimo; Glauco, Sbrana (1967). Preparation of hydroquinone US3459812 A (PDF). Lonza Ag.
- ^ Holmes, J.; Hagemeyer, H. (1971). Process for the production of hydroquinone US 3742071 A (PDF). Eastman Kodak Co.
- ^ a b c Shi Y, Xia Y, Xu G, Wen L, Gao G, Zong B (28 October 2021). "Hydrogen peroxide and applications in green hydrocarbon nitridation and oxidation". Chinese Journal of Chemical Engineering (Review article). 41: 145–161. doi:10.1016/j.cjche.2021.09.030. S2CID 240248911.
- ^ See:
- Pelletier and Caventou (1820) "Recherches chimiques sur les quinquinas" (Chemical investigations of quinquinas [i.e., the bark of various Cinchona trees]), Annales de Chimie et de Physique, 2nd series, 15 : 289–318, 337-364. On pages 341-342, the preparation and properties of l'acide pyro-kinique (pyroquinic acid or hydroquinone) are discussed.
- Roscoe, Henry (1891). A Treatise on Chemistry, Volume 3, Part 3. London: Macmillan & Co. p. 165.
- ^ Streitwieser, Andrew (1992). Introduction to organic chemistry. Heathcock, Clayton H., 1936-, Kosower, Edward M. (4th ed.). Upper Saddle River, N.J.: Prentice Hall. ISBN 978-0139738500. OCLC 52836313.
- ^ Additive manufacturing of ceramics from preceramic polymers Additive manufacturing 2019 vol. 27. pp 80-90
- ^ Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products
- ^ "Clear N Smooth Skin Toning Cream recalled". 4 October 2011. Retrieved 4 April 2018.
- ^ a b United States Food and Drug Administration (2006). Skin Bleaching Drug Products for Over-the-Counter Product Use; Proposed Rule (PDF) (Report). 1978N-0065. Archived (PDF) from the original on 16 May 2011.
- ^ "Congress Enacts OTC Monograph Reform". JD Supra. Retrieved 19 December 2021.
- ^ a b Research, Center for Drug Evaluation and. "About the Center for Drug Evaluation and Research - Hydroquinone Studies Under The National Toxicology Program (NTP)". www.fda.gov. Archived from the original on 22 January 2017. Retrieved 12 February 2017.
- ^ Campaign For Safe Cosmetics - Hydroquinone Archived 27 November 2010 at the Wayback Machine
- ^ Olumide, YM; Akinkugbe, AO; Altraide, D; Mohammed, T; Ahamefule, N; Ayanlowo, S; Onyekonwu, C; Essen, N (April 2008). "Complications of chronic use of skin lightening cosmetics". International Journal of Dermatology. 47 (4): 344–53. doi:10.1111/j.1365-4632.2008.02719.x. PMID 18377596. S2CID 8159382.
- ^ "Hydroquinone 10022-H". ntp.niehs.nih.gov. Archived from the original on 1 October 2017. Retrieved 18 August 2023.
- ^ Draelos, Zoe Diana (1 September 2007). "Skin lightening preparations and the hydroquinone controversy". Dermatologic Therapy. 20 (5): 308–313. doi:10.1111/j.1529-8019.2007.00144.x. ISSN 1529-8019. PMID 18045355. S2CID 24913995.
- ^ Bandyopadhyay, Debabrata (1 January 2009). "Topical treatment of melasma". Indian Journal of Dermatology. 54 (4): 303–309. doi:10.4103/0019-5154.57602. ISSN 0019-5154. PMC 2807702. PMID 20101327.
- ^ Mazurek, Klaudia; Pierzchała, Ewa (1 September 2016). "Comparison of efficacy of products containing azelaic acid in melasma treatment". Journal of Cosmetic Dermatology. 15 (3): 269–282. doi:10.1111/jocd.12217. ISSN 1473-2165. PMID 27028014. S2CID 25303091.
- ^ Mansouri, P.; Farshi, S.; Hashemi, Z.; Kasraee, B. (1 July 2015). "Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial". The British Journal of Dermatology. 173 (1): 209–217. doi:10.1111/bjd.13424. ISSN 1365-2133. PMID 25251767. S2CID 21618233.
- ^ "Hydroquinones". Phenols—Advances in Research and Application: 2013 Edition. Scholastic. 2013. p. 76.
- ^ Organic Chemistry, Solomon and Fryhle, 10th edition, Wiley Publishing, 2010.[page needed]
- ^ Joval, E; Kroeger, P; N (April 1996). "Hydroquinone: the toxic compound of Agaricus hondensis". Planta Medica. 62 (2): 185. doi:10.1055/s-2006-957852. PMID 17252436. S2CID 260249338.
- ^ Burdock, G.A. (1998). "Review of the biological properties and toxicity of bee propolis (propolis)". Food and Chemical Toxicology. 36 (4): 347–363. doi:10.1016/S0278-6915(97)00145-2. PMID 9651052.
- ^ The Beaver: Its Life and Impact. Dietland Muller-Schwarze, 2003, page 43 (book at google books)